5 news items
Vistagen to Present at the Jefferies Global Healthcare Conference
VTGN
29 May 24
to a new class of drugs known as pherines, which are investigational neuroactive nasal sprays with innovative proposed mechanisms of action
Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference
VTGN
23 May 24
candidates belong to a new class of drugs known as pherines, which are investigational neuroactive nasal sprays with innovative proposed mechanisms
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
VTGN
25 Apr 24
participants. These pilot findings contribute to our confidence in PH15's potential as an innovative treatment for enhancing psychomotor performance
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
VTGN
9 Apr 24
pipeline candidates belong to a new class of drugs known as pherines, which are investigational neuroactive nasal sprays with innovative proposed mechanisms
Vistagen to Present at Stifel 2024 Virtual CNS Days
VTGN
11 Mar 24
of drugs known as pherines, which are investigational neuroactive nasal sprays with innovative proposed mechanisms of action that activate
- Prev
- 1
- Next